PuSH - Publication Server of Helmholtz Zentrum München

Weidle, U.H.* ; Dickopf, S.* ; Hintermair, C. ; Kollmorgen, G.* ; Birzele, F.* ; Brinkmann, U.*

The role of micro RNAs in breast cancer metastasis: Preclinical Validation and potential therapeutic targets.

Cancer Genomics Proteomics 15, 17-39 (2018)
Publ. Version/Full Text DOI PMC
Open Access Gold
Despite the approval of several molecular therapies in the last years, breast cancer-associated death ranks as the second highest in women. This is due to metastatic disease, which represents a challenge for treatment. A better understanding of the molecular mechanisms of metastasis is, therefore, of paramount importance. In this review we summarize the role of micro RNAs (miRs) involved in metastasis of breast cancer. We present an overview on metastasis-promoting, -suppressing and context-dependent miRs with both activities. We have categorized the corresponding miRs according to their target classes, interaction with stromal cells or exosomes. The pathways affected by individual miRs are outlined in regard to in vitro properties, activity in metastasis-related in vivo models and clinical significance. Current approaches that may be suitable for therapeutic inhibition or restauration of miR activity are outlined. Finally, we discuss the delivery bottlenecks which present as a major challenge in nucleic acid (miR)-based therapies.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
2.432
0.708
34
42
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Review
Keywords Colonization Of Distinct Organs ; Epithelial-mesenchymal Transition (emt) ; Exosomes ; Mesenchymal-epithelial Transition (met) ; Metastasis-related In Vivo Models ; Migration And Invasion ; Review ; Tumor Cell/stromal Cell Interactions
Language
Publication Year 2018
Prepublished in Year 2017
HGF-reported in Year 2017
ISSN (print) / ISBN 1109-6535
e-ISSN 1790-6245
Quellenangaben Volume: 15, Issue: 1, Pages: 17-39 Article Number: , Supplement: ,
Publisher International Institute of Anticancer Research
Reviewing status Peer reviewed
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-502890-001
Scopus ID 85040185985
PubMed ID 29275360
Erfassungsdatum 2018-01-24